COLL

Collegium Pharmaceutical, Inc. Common Stock

45.37

USD

COLL Earnings Reports

Positive Surprise Ratio

COLL beat 19 of 40 last estimates.

48%

Next Report

Date of Next Report

Feb 19, 2026

Estimate for Q4 25 (Revenue/ EPS)

$210.29M

$2.37

Implied change from Q3 25 (Revenue/ EPS)

+0.44%

+5.33%

Implied change from Q4 24 (Revenue/ EPS)

+15.57%

+33.90%

Collegium Pharmaceutical, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, COLL reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 2.08 USD, resulting in a 7.92% surprise. Revenue reached 209.36 million, compared to an expected 192.90 million, with a 8.53% difference. The market reacted with a +13.42% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 8 analysts forecast an EPS of 2.37 USD, with revenue projected to reach 210.29 million USD, implying an increase of 5.33% EPS, and increase of 0.44% in Revenue from the last quarter.

FAQ

What were Collegium Pharmaceutical, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Collegium Pharmaceutical, Inc. Common Stock reported EPS of $2.25, beating estimates by 7.92%, and revenue of $209.36M, 8.53% above expectations.

How did the market react to Collegium Pharmaceutical, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 13.42%, changed from $35.85 before the earnings release to $40.66 the day after.

When is Collegium Pharmaceutical, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 19, 2026.

What are the forecasts for Collegium Pharmaceutical, Inc. Common Stock's next earnings report?

Based on 8 analysts, Collegium Pharmaceutical, Inc. Common Stock is expected to report EPS of $2.37 and revenue of $210.29M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.